Cerebrospinal fluid (CSF) drains via the lymphatic drainage pathway. This lymphatic pathway connects the central nervous system (CNS) to the cervical lymph node (CLN). As the CSF drains to CLN via the dural and nasal lymphatics, T cells and antigen presenting cells pass along the channels from the subarachnoid space through the cribriform plate. Human immunodeficiency virus (HIV) may also egress from the CNS along this pathway. As a result, HIVegressing from the CNS may accumulate within the CLN. Towards this objective, we analyzed CLNs isolated from rhesus macaques that were chronically-infected with simian immunodeficiency virus (SIV). We detected significant accumulation of SIV within the CLNs. SIV virion trapping was observed on follicular dendritic cells (FDCs) localized within the follicular regions of CLNs. In addition, SIV antigens formed immune complexes when FDCs interacted with B cells within the germinal centers. Subsequent interaction of these B cells with CD4+ T follicular helper cells (T FHs ) resulted in infection of the latter. Of note, 73% to 90% of the T FHs cells within CLNs were positive for SIV p27 antigen. As such, it appears that not only do the FDCs retain SIV they also transmit them (via B cells) to T FHs within these CLNs. This interaction results in infection of T FHs in the CLNs. Based on these observations, we infer that FDCs within the CLNs have a novel role in SIV entrapment with implications for viral trafficking.
Introduction
Influx of HIV into the central nervous system (CNS) begins early during infection, long before symptoms of neuroAIDS arise (Spudich et al. 2011) , via infected cells or free virus particles that cross the blood brain barrier (BBB) (Avison et al. 2004) . Eventually, HIV reservoirs are established in cells or tissues that harbor replication-competent virus for prolonged periods of time. The viral reservoir is an archive of viral sequences representative of earlier stages of infection (Matyszak and Perry 1996; Pashenkov et al. 2001; Smith et al. 2001) . Both HIV patients and simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs) exhibit persistently high levels of viral DNA positive cells, with profound immune activation during combination antiretroviral therapy (cART) (Edén et al. 2007; Zink et al. 2010) . Despite effective cART, HIV viral reservoirs persist and represent a major roadblock of antiviral therapy interruption strategies and HIV cure strategies. The resident CNS cells like, perivascular macrophages and glial cells have been thought to be potent reservoir sites for HIV infection, thereby limiting the success of cART in completely suppressing viral replication within the CNS (Williams et al. 2001; Fois and Brew 2015; Churchill and Nath 2013) . The viral gene flow between the meninges and deep brain tissues was also reported upon HIV-1 infection (Lamers et al. 2011) .
Functional meningeal lymphatic system facilitates the drainage of the cerebrospinal fluid (CSF) to the cervical lymph nodes (CLNs) (Louveau et al. 2015a, b; Engelhardt et al. 2016; Mohammad et al. 2014; Andres et al. 1987; Yang et al. 2013; Aspelund et al. 2015) . This system also allows immune cells to migrate from cribriform plate into the lymphatic system of nasal mucosa and then into deep cervical lymph nodes (CLNs) (Louveau et al. 2015b ). This meningeal lymphatic system creates a direct link to deep CLNs enabling drainage of CSF and immune cells egressing from the CNS (Louveau et al. 2015b; Mohammad et al. 2014 ). CLNs constitute a cluster of numerous lymph nodes found in the collar region. These CLNs are a major site for systemic activation of CNS specific T cells, after presentation of antigen entrapped in dendritic cells (DCs) (van Zwam et al. 2009; Ling et al. 2006 ). CNS-derived antigens have been shown to induce immune responses in the deep CLNs (Cserr et al. 1992) . Circulating conventional DCs (cDCs) had been shown to migrate through the rostral migratory stream (RMS) toward the olfactory bulb draining into CLNs (Mohammad et al. 2014) . In this respect, we and others have clearly established trafficking of cDCs into the CNS in response to neuroinflammation (Matyszak and Perry 1996; Pashenkov et al. 2001; Sagar et al. 2012a, b; Jain et al. 2010; Serafini et al. 2000; Zozulya et al. 2009; Hatterer et al. 2008 ). More recently, we have provided evidence for the presence of cDCs in the brain parenchyma of SIV-infected RMs (Hollenbach et al. 2014) .
In periphery, cDCs carrying HIV migrate into peripheral lymph nodes where they infect and prime T cells in the T-cell zone, which then move toward the B-cell follicles (BCFs). These BCFs harbor a specialized type of dendritic cell population designated follicular dendritic cells (FDCs) (Kepler and Perelson 1993; Heesters et al. 2013) , which can bind and retain antigen on their dendritic processes for months to years in the form of immune complexes (Grouard et al. 1996; Aguzzi and Krautler 2010) . BCFs have been postulated as important compartments for both latent and active viral reservoirs during treatment (Deleage et al. 2016) . In HIV disease, virion-immune complexes get trapped on the processes of FDCs, which interconnect to form a dense meshwork and represent the largest repository of virus in the body for longer time periods (Matyszak and Perry 1996; Smith et al. 2001; Grouard et al. 1996; Heesters et al. 2014) . FDCs have recently been shown to retain infectious HIV inside endosomes, indicating the migration of virions across these cells (Heesters et al. 2015) . Interestingly, FDCs have been shown to retain infectious HIV particles even in the presence of neutralizing antibodies, and infectious virus has been rescued from FDCs from HIV-infected patients on suppressive cART for up to 24 years, suggesting that FDCs represent a significant reservoir of diverse HIV (Smith et al. 2001; Heesters et al. 2015; Keele et al. 2008; Banki et al. 2005; Zhou et al. 2011; SmithFranklin et al. 2002) . Furthermore, even with suppressive antiretroviral therapy, replicating virus can persist to replenish FDC network (Rothenberger et al. 2015) . A similar pathway might exist for HIVantigens and HIV-infected cells from CNS to CLNs that are particularly important in the context of CNS related immune responses. Understanding viral distribution within the CLNs may shed new light on HIV infection of the CNS. The present study is the first attempt in this direction providing clear evidence for the abundance of SIV virions within FDCs' network of deep CLNs.
Materials and Methods

Animals and Samples
A total of 11 SIV infected adult Indian rhesus macaques along with a naïve control animal were utilized in this study. All animals were maintained at the Yerkes National Primate Research Center of Emory University (Atlanta GA) in accordance with the regulations of the Committee on the Care and Use of Laboratory Animal Resources. All experiments were approved by the local institutional biosafety review and animal use and care committees. Rhesus macaques were inoculated intravenously with 200 TCID 50 (50% tissue culture infective dose) of SIVmac251. Peripheral blood samples were obtained concurrent with the times of biopsy samples. Peripheral blood mononuclear cells (PBMCs) were isolated from blood of SIV infected rhesus macaques, using standard Ficoll-Hypaque gradient procedure. Plasma viral RNA (vRNA) loads were measured in the corresponding blood samples. CLNs and other tissues were collected immediately after euthanasia from all animals for in situ techniques and flow cytometry analysis. Tissues were fixed by immersion in freshly prepared 4% paraformaldehyde and embedded in paraffin. To collect CLN cells, tissue was minced and sieved through 40-μm nylon cell strainers (Fisher Scientific, Pittsburgh, PA) with a 10 ml syringe plunger. 
Ethics Statement
Necropsy
Animals showing signs of clinical end points relative to disease progression were humanely euthanized with an intravenous overdose of pentobarbital sodium according to the guidelines of the American Veterinary Medical Association. A complete necropsy was performed on these animals. For histopathology or immunohistochemical examination, selected tissue samples were fixed overnight in 4% paraformaldehyde, embedded in paraffin and sectioned at 4 μm.
Quantitative RT-PCR and Quantitation of SIV RNA in Plasma
Plasma and tissue RNA was isolated using the QiaAmp vRNA Mini-procedure and RNeasy Mini procedure, respectively, as described by the manufacturer (Qiagen, Germantown MD). vRNA levels were measured by quantitative RT-PCR (qRT-PCR) as described previously. The assay sensitivity was 50 vRNA copies per ml for plasma. RNA copy numbers in tissues were normalized and represented as SIV RNA copies per ng of total RNA (Byrareddy et al. 2014 ).
Immunohistochemistry
Immunohistochemistry (IHC) was performed using 4 μm thick, formalin fixed, FFPE tissue sections. Slides were baked, deparaffinized in xylene, and passed through a series of increasing percentage of alcohols. Subsequently, antigen was retrieved with 10 mM citrate buffer, pH 6.0 in a water bath warmed to 95°C for 1 h. Slides were cooled to room temperature for 20 min and washed three times for 5 min with phosphate buffered saline (PBS) containing 0.05% Tween 20. Subsequently, slides were incubated for 30 min in PBS containing 0.1% Triton X-100. Slides were blocked with 10% normal goat serum (Jackson ImmunoResearch, West Grove PA) and subsequently incubated with 1:50 dilution of anti-CD35 and SIV gag (p27) monoclonal antibody (clone 55-2F12) in PBS overnight at 4°C. Slides were washed three times in PBS containing 0.025% Triton X-100, and treated with HRP-conjugated Goat anti-mouse (Novus Biologicals, Littleton CO) for 1 h at room temperature. After further washing, immunoperoxidase staining was developed using DAB chromogen procedure as described by the manufacturer (Biocare Medical, Concord CA) for 10 min. Slides were counterstained with hematoxylin and mounted with permount aqueous mounting medium.
Immunofluorescence Staining and Quantitative Image Analysis
Immunofluorescence (IF) staining and quantitative image analysis was performed with frozen CLN sections of 4-5 μm thickness. Tissue Sections were baked overnight on glass slides at 55°C to firmly affix and dehydrate the tissue. Paraffin-embedded rhesus macaque CLN tissue sections were deparaffinized in xylene and rehydrated in a graded series of alcohol. Briefly, slides were immersed twice in 100% xylene for 3 min followed by a 3 min wash with a 1:1 solution of xylene and 100% ethanol. Subsequently, tissue sections were washed in 100, 95, 70 and 50% ethanol followed by a coldwater bath, each for 3 min. Thereafter, tissue sections were boiled in 10 mM sodium citrate, pH 6.0 for 20 min, followed by three 5 min washes with PBS containing 0.05% Tween 20. For p27 and PD-1 staining, tissue sections were permeabilized in 0.1% triton X-100. Tissue sections were blocked with the Sniper reagent (Biocare, Concord CA) for 15 min. After blocking, tissue sections were stained with unconjugated primary mouse anti-human CD35 (clone E11; Novus Biologicals, Littleton CO), rabbit anti-human CD20 (polyclonal, Thermo Scientific, Rockford IL), goat anti human PD-1 (C-16, Santa Cruz Biotech, Dallas TX), mouse antip27 SIV gag (clone 55-2F12, AIDS Research and Reference Reagent Program, Germantown MD) or fluorescein peanut agglutinin (PNA) (Vector Labs, Burlingame CA) at a dilution ranging from 1:20 to 1:100 in PBS containing 1% BSA and incubated overnight at 4°C. Thereafter, tissue sections were washed and incubated with secondary fluorophore conjugated antibodies (TRITC-conjugated donkey anti-mouse, DyLight405-conjugated donkey anti-rabbit, DyLight405 conjugated donkey anti-goat or FITC-conjugated goat anti-mouse antibodies; Jackson Labs, West Groove PA) at a dilution ranging from 1:100-1:500 in PBS containing 1% BSA for 1 h at room temperature. Since anti-CD35 and anti-p27 antibodies were generated in mouse, tissue sections were blocked after first primary antibody with 10% normal mouse serum followed by incubation with Fab fragment donkey anti-mouse (Jackson ImmunoResearch, West Groove PA) for 1 h at room temperature. Subsequently, tissue sections were incubated with the second primary antibody and corresponding secondary antibodies. Tissue sections were washed three times in PBS containing 0.025% Triton X-100. Where indicated, tissue sections were counter-stained with 0.5 μg/ml DAPI for 10 min at room temperature, rinsed, and mounted in prolong gold antifade reagent (ThermoFisher, Waltham MA). Images were acquired using the Olympus IX81 inverted microscope at 10×, 20×, 40× or 100× objectives or Olympus 1X81 confocal microscope using 60× objective lens. The interaction of FDCs (CD35) with T FH (PD-1) and B cells (CD20) was shown as colocalization sharing p27 antigen at their membranes. The formation of T FH and B-cell stable complex was demonstrated in a similar manner.
Flow Cytometry
CLNs were harvested immediately after euthanasia; minced and treated with collagenase as described previously (Heesters et al. 2015) . Cells were then sieved through 40-μm nylon cell strainers with a 10-ml syringe plunger to make a cell suspension. Isolated cells were >90% viable as assessed by trypan blue exclusion. Cells were stained for surface antigens by incubating with fluorochrome-conjugated antibodies in staining buffer (PBS containing 2% fetal calf serum) for at least 30 min protected from light. The following fluorochromeconjugated antibodies were used: CD20 (2H7), CD28 (CD28.2), CD35 (E11), CD4 (OKT-4), CD80 (2D10), CD95 (DX2), CXCR4 (12G5), ICOS (C398.4A) and PD-1 (EH12.2H7, Biolegend San Diego CA); CD21 (B-ly4), CD23 (M-L233), CD3 (SP34-2) and CD32 (8.26) (BD Biosciences, San Jose CA); and CXCR5 (MU5UBEE) (eBioscience, San Diego CA). FDCs were stained with Alexa Fluor® 488-conjugated SIVmac p27 antibody (55-2F12) or the isotype control IgG2b antibody without and with permeabilization in conjunction with the collagenase treatment. TFHs were also stained intracellularly with conjugated anti-p27 (55-2F12) or IgG2b and also BCL-6 (K112-91) or IgG1k (MOPC-21) (BD Biosciences). Collagenase (Sigma) treatment was performed with 1 mg/ml at 37°C for 10 min and permeabilization was performed by utilizing FOXP3/ Transcription factor staining buffer (eBioscience, San Diego CA). Cells were fixed in intracellular fixation buffer for 30 min at room temperature in dark then washed twice in 1X permeabilization buffer before being resuspended in 1X buffer containing fluorochrome labeled antibody for detection of intracellular antigen. Cells were incubated for 45 min at room temperature in the dark, washed twice in 1X permeabilization buffer and resuspended in staining buffer for acquisition. LIVE/DEAD® Fixable Dead Cell Stain (Life Technologies, Carlsbad CA) was used to gate for the live cells. Samples were acquired on a BD LSRFortesa and analyzed using FlowJo software (Tree Star, Ashland OR).
Results
Chronic Infection with SIV Results in Varying Levels of Viral RNA Loads in Plasma, PBMCs and CLNs To assess the level of SIV infection in rhesus macaques, SIV vRNA levels were measured at the time of necropsy in the plasma (up to 29 weeks after intravenous inoculation) in 11 SIVmac251 infected rhesus macaques. SIV vRNA was detected in plasma of all animals and ranged from 10 3 to 10 6 copies/mL (Fig. 1a) . Thus, a robust chronic SIV infection was established in all 11 RMs that were infected. SIV vRNA was detected in plasma as early as one week after inoculation, peaked between 2 and 3 weeks, and remained at high set-point (10 3 - 10 6 ) levels until the end of the study (week 20-29) (Fig. 1c) . Next, SIV vRNA levels were assessed in the PBMCs and CLNs to determine the relative difference in the magnitude in viral burden and infection between these two compartments. SIV vRNA levels expressed as copies/ng of RNA was found to be at significantly higher levels in the CLNs (p = 0.004) as compared to PBMCs (Fig. 1b) . Typically, we expect to obtain approximately 50 μg of total RNA from 100 mg of tissue samples and 8 μg total RNA from 1 × 10 6 PBMCs or lymphoid cells.
B-Cell Follicles within CLNs Trap High Levels of SIV
Having established the presence of SIV vRNA in CLNs, we sought to determine whether SIV could be detected in BCFs within CLN. We also included 2 CLNs from SIV-naïve RMs for staining with hematoxylin-eosin to identify BCFs (Fig. 2a) . The relative abundance of SIV burden was first determined on FDCs in the CLNs by immunohistochemistry for SIVp27 (Fig. 2a) . Cells stained with SIVp27 gag protein were observed in CLNs obtained from chronically SIV-infected rhesus macaques, but not in the corresponding SIV-negative controls as seen by alkaline phosphatase based fast red ( Fig. 2e-f ) and DAB ( Fig. 2g-h ) chromogens. Therefore, chronic SIV infection of rhesus macaques resulted in substantial SIVacquisition by FDCs in the BCFs of CNS draining CLNs, in addition to accumulation shown in peripheral LNs by others (Grouard et al. 1996; Aguzzi and Krautler 2010) .
FDCs Entrap Substantial Load of Viral Antigen within CLNs
To identify virus harboring cells within BCFs, IHC and IF analyses were performed to identify FDCs, B-cell aggregates, GCs and SIV by staining with CD35, CD20, PNA and SIVp27 antibodies, respectively. We observed CD20+ B-cell aggregates in BCFs (Fig. 3a) . Then we looked for FDC architecture within BCFs. The signature reticular pattern of FDCs was clearly observed in the CLN BCFs by IF using confocal microscopy ( Fig. 3b) . CLNs from SIV naïve rhesus macaques were populated with CD35 expressing FDCs (Fig. 3b ) without any overlap with CD20+ B cells especially within the center of GCs (Fig. 3c) . To confirm that FDCs harbored SIV, IF analysis was performed on CLN sections from SIV infected rhesus macaques for SIVp27, CD35 and DAPI (Fig. 3d) . A significant proportion of FDCs within BCFs of the CLNs were observed positive for SIV p27 staining (Fig. 3d) .
Having established the quantitative measure of SIV burden on FDCs in BCFs of CLN in vivo, further ex vivo studies were performed to better understand SIV acquisition by the FDCs. Cells were isolated from CLNs and characterized by surface and intracellular staining to determine FDC retention of SIV using antibodies to CD35, CD20 and SIVp27, along with appropriate isotype controls. Consistent with what has been demonstrated in peripheral LNs, we observed FDC frequencies to be 12.84 ± 1.82% of total live cells to be CD35 + / CD20 − FDCs within CLNs (Fig. 4a) . These cells also expressed other FDCs markers such as CD21 and CD80 in good proportion 25.2% and 94.9%, respectively (Fig. 4a) .
In view of the ability of FDCs to trap antigen and retain it for an extended period of time, we assessed the frequency of FDCs carrying SIV mature gag protein p27 on the surface as well as within the cells. Without permeabilization, negligible presence of SIVp27 was observed on FDCs ( Fig. 4b) while a considerable proportion of FDCs (24.74 ± 6.03%, mean ± SEM) harbored intracellular SIVp27 (Fig. 4c) , irrespective of collagenase treatment. These results suggest FDCs' entrapped SIV virions were primarily inside the cells as shown earlier in case of inguinal LNs (Heesters et al. 2015) . (Fig. 5c) . Our confocal imaging also demonstrated the presence of SIVp27 antigen in T FH cells, which supports the notion of FDCs transferring SIV and infecting T FH cells in the BCFs of CLNs (Fig. 5c ). This exchange of antigens is significant, considering the ability of T FH cells to migrate from the BCFs and lymph nodes. We indeed observed higher proportion of infected T FH cells on the periphery of BCFs of CLNs as compared to the center of BCFs, where the proportion of antigen loaded FDCs was higher ( Supplementary Fig. 1 ).
Antigen Harboring FDCs Interact with B and T FH Cells in CLNs
Infected T FH Cells can Interact with B Cells in GC of CLNs
Finally, studies were performed to establish that SIV-infected T FHs could interact with B cells in the BCF. T FH cells express high levels of PD-1, which leads to decreased T FH proliferation. In this regard, the qualitative nature of T FH and B-cell interactions was determined by confocal microscopy, which demonstrated PD-1 hi expressing, infected T FH cells surrounded by B cells (Fig. 5d ). This interaction seems to be significant, considering the association between these complexes and hypergammaglobunemia in HIV patients. Thereafter, infected PD-1 hi TFH cells were shown by colocalization of PD-1 and SIVp27 (Fig. 6a) . To confirm the quantitative nature of T FH cell infection, flow cytometry was performed (Fig. 6b) . Cells isolated from CLNs were examined for CD4, CD3, PD-1, CXCR5, BCL6, ICOS, CXCR4, CD95 and CD28 expression (Fig. 6b,c) . CD4
+ cells (Fig. 6b) were analyzed for intracellular expression of SIVp27 along with isotype controls (Fig. 6d lower panel) . CD4 + PD-1 + T FH cells ranged from 0.65% to 3.49% of total CD4+ T cells isolated from CLNs (Fig. 6b, d (Fig. 6d) . Thus, not only do FDCs harbor and present SIV to B cells within BCF of CLNs, SIV infection is established in T FH cells. 
Discussion
In this study, we attempted to establish that SIV trapped on the FDC network within CLNs may provide an additional viral reservoir, which would be distinct from the latent or persistent CNS reservoir that exists in perivascular macrophages, microglia and astrocytes. Although the presence of viral antigens was observed on FDCs in CLNs and in the sharing of antigen from FDCs to B cells and T FH cells, future studies are required to more firmly establish the role of FDCs in CLNs as a viral reservoir and the relationship between this reservoir and viruses within the CNS. Furthermore, we need to investigate in greater detail the role of myeloid cell trafficking into the CNS and establish the significance of FDC accumulated virus in HIV infection. Monocyte trafficking into tissues is crucial to understand viral persistence during cART and its impact on HIV disease. These cells undergo continuous slow trafficking from blood to tissues and differentiate into macrophages and immature dendritic cells via afferent lymphatics. As such, they may contribute to establishment of cellular reservoirs that are unaffected by cART (Crowe et al. 2003; Randolph et al. 2002) .
A significant proportion of FDCs within CLNs were observed to harbor SIV, after establishment of primary infection. Indeed, SIV harboring FDCs were shown here to directly interact and co-localize with B and T FH cells. This interaction is significant as it can lead to antigen-specific memory B-cell response and the infection of T FH cells, respectively. Finally, we also demonstrated that B-cells are in intimate contact with T FH cells, which has been found to be associated with hypergammaglobulinemia, a means of immune response evasion by HIV (Lindqvist et al. 2012) . Based on these observations, we infer a novel role for CLN FDCs in viral entrapment and creation of a persistent SIV reservoir with potential importance to HIV neurological infections. Hence, our study highlights the role of FDCs in accumulation and transmission of HIV with implications for HIV egress from the CNS.
FDCs are known to act as an archive of infection and possess ability to indirectly infect nearby CD4 + T FH cells via an immune synapse involving B cells (Heesters et al. 2014) . FDCs are in direct contact with B cells and T FHs. It has been reported that human FDCs isolated from patients on cART retain infectious virus within a non-degradative cycling compartment. FDCs retain and recycle virus immune complexes, and as such only a fraction of the virus need be present on the FDC network and the remaining fraction may be retained in the endosomal compartment. This FDC retained virus is able to infect CD4+ T cells in in vitro experiments (Heesters et al. 2015) . These observations add further support to our studies and the potential impact of FDC associated virus in HIV disease.
Long lived reservoirs pose the most significant obstacle to a cure of HIV. While much has been gleamed from studies of CD4+ T cell reservoirs, less is known about other cellular or tissue reservoirs, including the CNS. A direct link between the CNS with CLNs via the meningeal lymphatic system has been demonstrated (Louveau et al. 2015a; Engelhardt et al. 2016; Louveau et al. 2015b; Mohammad et al. 2014; Andres et al. 1987; Yang et al. 2013 ). BGlymphatics^refers to a tunnel of astrocytes (a subpopulation of glial cells) surrounding the blood vessels in the brain. They have been shown to be responsible for flow of brain interstitial fluid into cerebrospinal fluid (CSF) (Yang et al. 2013; Iliff et al. 2012) . Interstitial fluid first drains from brain parenchyma to CSF via glymphatics (Yang et al. 2013; Iliff et al. 2012; Xie et al. 2013 ). Subsequently, the flow of interstitial fluid into the CLNs involves dura mater lymphatic vessels. The connection of the CNS to the lymphatic system has been demonstrated in infectious disease models (i.e. cerebral malaria) (Hoffmann et al. 2016 ) and in the maintenance of immune tolerance to self-antigens in the CNS (Mohammad et al. 2014) . This route has also been proposed for the migration of HIV infected cells out of the brain (Lamers et al. 2016) . However, no studies have specifically looked at the role of CLNs in HIV infection so far. We hypothesized that cDCs upon entering into the CNS may encounter HIV virions or proteins released from productively infected cells (such as long-lived macrophages and microglia) or apoptotic bodies of short-lived perivascular macrophages. Thereafter, infiltrating into CSF and moving from cribriform plate to the lymphatic system of the nasal mucosa finally draining into deep CLNs.
To test our hypothesis, we first presented evidence for the accumulation of the virus in CLNs. Levels of viral RNA were shown to be significantly higher in CLNs than PBMCs of SIV infected rhesus macaques. Reports in the past have shown similar observations in peripheral lymph nodes (Jobe et al. 1999; Saksela et al. 1993) . The majority of SIV burden within CLNs was found to be contained in the BCFs on FDCs, which is in line with previous reports for peripheral lymph nodes (Gerdes and Flad 1992) . Given FDCs established role as an HIV-1/SIV reservoir (Smith et al. 2001; Heesters et al. 2013 Heesters et al. , 2014 Aguzzi and Krautler 2010; Keele et al. 2008; Banki The surface expression of p27 was found to be negligible on FDCs. A considerable proportion of FDCs (24.74 ± 6.03%, mean ± SEM) harbored intracellular SIVp27. Blue and red line on the histograms corresponds to p27 and isotype control antibodies, respectively et al. 2005; Gerdes and Flad 1992) , we determined that as high as 39% of the total FDCs in samples from CLNs harbored SIV (as measured by SIVp27 protein staining). This virus could either be bound on the surface of FDCs or within the cycling endosomes for extended periods of time (Heesters et al. 2013 (Heesters et al. , 2015 Tacchetti et al. 1997) . Subsequent interactions of these FDCs with BCF trafficking target cells might result in infection of these cells and may also provide a route of virus egress out of the CLNs and into the CNS. Consistent with FDCs studied from other LNs, FDCs from CLNs of SIV-infected rhesus macaques are also a site for significant viral accumulation. HIV held on the surface of FDCs does not replicate or evolve; however, it retains the ability to infect cells that traffic nearby (Keele et al. 2008) . Importantly, although FDCs themselves remain uninfected, they reside immediately adjacent to activated CD4 + T and B cells within GCs and the long dendritic processes of FDCs interact directly with these adjacent lymphocytes. CD4 + T-follicular helper (T FH ) cells are a specialized CD4 + T-cell population in the BCF and play a seminal role in formation of the GC (Fazilleau et al. 2009 ). Of note, FDCs can facilitate infection of CD4 + T FH cells (SmithFranklin et al. 2002; Estes et al. 2004; Thacker et al. 2009 ).
In order to assess the cellular interactions of FDCs harboring SIV in BCFs of CLNs, we identified cellular complexes of FDCs with B cells in chronically SIV-infected CLNs using confocal microscopy. These interactions could lead to the development of SIV specific germinal center reactions and memory B-cell responses in CLNs, as well as potentially being 2a source of the hypergammaglobulinemia that is a hallmark of HIV/SIV infections. In addition to their capability to retain immune complexed antigen, FDCs have been shown to attract B cells and specific T cells into the BCFs to generate germinal center reactions (Ansel et al. 2000; Caux et al. 1995; Heesters et al. 2014) . Consistent with what has been demonstrated in peripheral lymph nodes (Lindqvist et al. 2012; Perreau et al. 2013 ) (Haynes et al. 2007) , we demonstrate that SIV harboring FDCs intimately interact with T FH cells within BCFs and that a high frequency of T FH are infected with SIV in CLNs. Since T FH , and other CD4+ T cell subsets, are dynamic cells that migrate out of lymph nodes (Suan et al. 2015) , the interactions between FDCs and T FH in CLNs may be important in the context of understanding CNS infection. The interaction between T FH and B cells increases the turnover of B cells in the follicles of peripheral lymph nodes. This strong interaction between T FH and B cells has been demonstrated in a number of studies (Lindqvist et al. 2012; Perreau et al. 2013; Hong et al. 2012; Petrovas et al. 2012; Fahey et al. 2011) . Furthermore, the expansion of T FH cells in lymphoid tissues has been found to be associated with high titers of virus specific antibodies and heightened proliferation of B cells (Hong et al. 2012; Petrovas et al. 2012; Margolin et al. 2002) . In this regard, the formation of complexes with B and T FH cells with antigen shared between the two could be demonstrated. A positive correlation between the T FH cells in peripheral lymph nodes and hypergammaglobunemia has also been demonstrated by few studies, which contributes to production of large amounts of nonspecific antibodies and evasion of immune response by virus (Lindqvist et al. 2012) . Collectively, these interactions between FDCs, B and T FH cells indicate that not only do FDCs act as carriers of SIV, but they also possess the capacity to infect the neighboring cells, an observation consistent with the characteristic features of viral reservoirs.
While our study highlights that HIV is trapped on FDCs, forms immune complexes with B cells and infects T FH in CLNs, yet these observations are a prelude to determining that HIV trapped on FDCs in CLNs is a potential reservoir site. To unequivocally establish this viral reservoir site, one of the component of these studies will necessitate assessment and comparison of viral genotypes present in the periphery with virus in CNS perivascular macrophages, microglial cells, astrocytes and those associated with FDCs in CLNs in order to define the relationship of viruses between these compartments. These future studies will be instrumental in establishing pathways of viral egress from the CNS into the periphery as well as determine the putative link between CNS infection and CLN reservoirs during the course of disease. Additional studies will also be essential to assess the phenotypic properties of viruses in the CLNs, which will confirm the pathogenicity of the virus in the CLNs and establish this site as a direct link with CNS infection. Overall, we have demonstrated that identification of additional reservoirs that may be involved in seeding additional genotypes back into the CNS.
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